Skip to Content

SANKYO C22 (Hydrochlorothiazide and olmesartan medoxomil 12.5 mg / 20 mg)

Pill with imprint SANKYO C22 is Yellow, Round and has been identified as Hydrochlorothiazide and olmesartan medoxomil 12.5 mg / 20 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 12.5 mg / 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for SANKYO C22

Hydrochlorothiazide and olmesartan medoxomil

Imprint:
SANKYO C22
Strength:
12.5 mg / 20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin II inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC):
57664-0758

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide